We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Chemours (CC) to Post Q2 Earnings: What's in the Cards?
Read MoreHide Full Article
The Chemours Company (CC - Free Report) is set to release second-quarter 2022 results after the bell on Jul 28. It is likely to have gained from higher customer adoption of the Opteon platform, favorable prices and efforts to reduce costs. However, a weaker automotive production is likely to have affected its quarterly performance. The company is expected to have faced some headwinds from raw material cost inflation and ore constraints in the quarter.
The company beat the Zacks Consensus Estimate for earnings in three of the last four quarters, while missing once. It has a trailing four-quarter earnings surprise of roughly 28.7%, on average. The company posted an earnings surprise of 58.7% in the last reported quarter.
Chemours’ shares have increased 3.9% in the past year against a 12.2% decline of the industry.
Image Source: Zacks Investment Research
Let’s see how things are shaping up for this announcement.
What Do Estimates Say?
The Zacks Consensus Estimate for Chemours’ second-quarter revenues is currently pegged at $1,819 million, suggesting an increase of about 9.9% on a year-over-year basis.
The Zacks Consensus Estimate for revenues in the Chemical Solutions unit is pegged at $33.4 million, calling for a roughly 64.5% decline year over year.
The Zacks Consensus Estimate for revenues in the Titanium Technologies division is pegged at $933 million, suggesting a rise of 8.6% year over year. The same for the Advanced Performance Materials unit is pinned at $431 million, reflecting an 11.9% sequential increase.
The consensus estimate for revenues for the Thermal & Specialized Solutions segment stands at $444 million, indicating a 4.5% sequential increase.
Some Factors at Play
Chemours is likely to have benefited from cost-management actions inthe second quarter. It has undertaken various measures to cut costs like reducing overhead and discretionary spending. The company’s cost, productivity and operational improvement actions across its businesses are likely to have supported margins.These measures are likely to have helped the company generate strong cash flows and margins in the quarter to be reported.
The company’s margins are also expected to have been driven by implemented price raises for certain products.Its Thermal & Specialized Solutions segment is also likely to have benefited from strong demand for refrigerants across most regions.
The company is likely to have gained from the increasing adoption of the Opteon platform in the quarter. It is witnessing higher demand for Opteon in mobile and stationary applications. Volumes in the Titanium Technologies division are also likely to have been driven by steady demand across all end markets and geographies.
However, Chemours is likely to have faced headwinds from weaker automotive production due to the global semiconductor shortage. Subdued auto build rates might have affected volumes in the secondquarter.
The company has been facing headwinds from global logistics and supply chain issues. It is being challenged by raw material cost inflation due to supply constraints. Some impact from these headwinds is likely to have persisted in the to-be-reported quarter. The company’s volumes are also likely to have been impacted due to ore constraints.
Zacks Model
Our proven model does not conclusively predict an earnings beat for Chemours this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here.
Earnings ESP: Earnings ESP for Chemours is +0.00%. The Zacks Consensus Estimate for second-quarter earnings is currently pegged at $1.42. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Chemours carries a Zacks Rank #4 (Sell).
Here are some companies in the basic materials space you may want to consider, as our model shows these have the right combination of elements to post an earnings beat this quarter:
The Zacks Consensus Estimate for Albemarle’s second-quarter earnings has been revised 21.5% upward in the past 60 days. The consensus estimate for ALB’s earnings for the quarter is currently pegged at $2.94.
Cabot Corporation (CBT - Free Report) , slated to release earnings on Aug 8, has an Earnings ESP of +0.16% and sports a Zacks Rank #1.
The consensus estimate for Cabot’s fiscal third-quarter earnings has been revised 1% upward in the past 60 days. The Zacks Consensus Estimate for CBT’s earnings for the quarter is pegged at $1.53.
Tronox Holdings Inc. (TROX - Free Report) , slated to release earnings on Jul 27, has an Earnings ESP of +3.57% and carries a Zacks Rank #3.
The consensus estimate for Tronox’s second-quarter earnings has been revised 0.6% upward in the past 60 days. The Zacks Consensus Estimate for TROX’s earnings for the quarter is pegged at 84 cents.
Image: Bigstock
Chemours (CC) to Post Q2 Earnings: What's in the Cards?
The Chemours Company (CC - Free Report) is set to release second-quarter 2022 results after the bell on Jul 28. It is likely to have gained from higher customer adoption of the Opteon platform, favorable prices and efforts to reduce costs. However, a weaker automotive production is likely to have affected its quarterly performance. The company is expected to have faced some headwinds from raw material cost inflation and ore constraints in the quarter.
The company beat the Zacks Consensus Estimate for earnings in three of the last four quarters, while missing once. It has a trailing four-quarter earnings surprise of roughly 28.7%, on average. The company posted an earnings surprise of 58.7% in the last reported quarter.
Chemours’ shares have increased 3.9% in the past year against a 12.2% decline of the industry.
Image Source: Zacks Investment Research
Let’s see how things are shaping up for this announcement.
What Do Estimates Say?
The Zacks Consensus Estimate for Chemours’ second-quarter revenues is currently pegged at $1,819 million, suggesting an increase of about 9.9% on a year-over-year basis.
The Zacks Consensus Estimate for revenues in the Chemical Solutions unit is pegged at $33.4 million, calling for a roughly 64.5% decline year over year.
The Zacks Consensus Estimate for revenues in the Titanium Technologies division is pegged at $933 million, suggesting a rise of 8.6% year over year. The same for the Advanced Performance Materials unit is pinned at $431 million, reflecting an 11.9% sequential increase.
The consensus estimate for revenues for the Thermal & Specialized Solutions segment stands at $444 million, indicating a 4.5% sequential increase.
Some Factors at Play
Chemours is likely to have benefited from cost-management actions inthe second quarter. It has undertaken various measures to cut costs like reducing overhead and discretionary spending. The company’s cost, productivity and operational improvement actions across its businesses are likely to have supported margins.These measures are likely to have helped the company generate strong cash flows and margins in the quarter to be reported.
The company’s margins are also expected to have been driven by implemented price raises for certain products.Its Thermal & Specialized Solutions segment is also likely to have benefited from strong demand for refrigerants across most regions.
The company is likely to have gained from the increasing adoption of the Opteon platform in the quarter. It is witnessing higher demand for Opteon in mobile and stationary applications. Volumes in the Titanium Technologies division are also likely to have been driven by steady demand across all end markets and geographies.
However, Chemours is likely to have faced headwinds from weaker automotive production due to the global semiconductor shortage. Subdued auto build rates might have affected volumes in the secondquarter.
The company has been facing headwinds from global logistics and supply chain issues. It is being challenged by raw material cost inflation due to supply constraints. Some impact from these headwinds is likely to have persisted in the to-be-reported quarter. The company’s volumes are also likely to have been impacted due to ore constraints.
Zacks Model
Our proven model does not conclusively predict an earnings beat for Chemours this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here.
Earnings ESP: Earnings ESP for Chemours is +0.00%. The Zacks Consensus Estimate for second-quarter earnings is currently pegged at $1.42. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Chemours carries a Zacks Rank #4 (Sell).
The Chemours Company Price and EPS Surprise
The Chemours Company price-eps-surprise | The Chemours Company Quote
Stocks That Warrant a Look
Here are some companies in the basic materials space you may want to consider, as our model shows these have the right combination of elements to post an earnings beat this quarter:
Albemarle Corporation (ALB - Free Report) , scheduled to release earnings on Aug 3, has an Earnings ESP of +11.9% and carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Albemarle’s second-quarter earnings has been revised 21.5% upward in the past 60 days. The consensus estimate for ALB’s earnings for the quarter is currently pegged at $2.94.
Cabot Corporation (CBT - Free Report) , slated to release earnings on Aug 8, has an Earnings ESP of +0.16% and sports a Zacks Rank #1.
The consensus estimate for Cabot’s fiscal third-quarter earnings has been revised 1% upward in the past 60 days. The Zacks Consensus Estimate for CBT’s earnings for the quarter is pegged at $1.53.
Tronox Holdings Inc. (TROX - Free Report) , slated to release earnings on Jul 27, has an Earnings ESP of +3.57% and carries a Zacks Rank #3.
The consensus estimate for Tronox’s second-quarter earnings has been revised 0.6% upward in the past 60 days. The Zacks Consensus Estimate for TROX’s earnings for the quarter is pegged at 84 cents.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.